Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market share analysis, 2017
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Significant surge in the number of ESRD patients
3.5.1.2. Rise in incidence of diabetes and hypertension
3.5.1.3. Shortage of kidneys for transplantation
3.5.2. Restraints
3.5.2.1. Risks and complications associated with dialyzers reuse
3.5.2.2. High cost associated with the hemodialysis
3.5.3. Opportunities
3.5.3.1. Technological advancements leading to better adoption
3.6. Patent Analysis (2016-2018)
3.6.1. Patent analysis, by year
3.7. Clinical Trials for Dialyzers
Chapter: 4: DIALYZER MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. High-flux dialyzer
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Low-Flux Dialyzer
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
Chapter: 5: DIALYZER MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. In-Center Dialysis
5.2.1. Market analysis, by country
5.3. Home Dialysis
5.3.1. Market analysis, by country
Chapter: 6: DIALYZER MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S. dialyzer market, by type
6.2.2.2. U.S. dialyzer market, by end user
6.2.2.3. Canada dialyzer market, by type
6.2.2.4. Canada dialyzer market, by end user
6.2.2.5. Mexico dialyzer market, by type
6.2.2.6. Mexico dialyzer market, by end user
6.2.3. North America dialyzer market, by type
6.2.4. North America dialyzer market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany dialyzer market, by type
6.3.2.2. Germany dialyzer market, by end user
6.3.2.3. France dialyzer market, by type
6.3.2.4. France dialyzer market, by end user
6.3.2.5. UK dialyzer market, by type
6.3.2.6. UK dialyzer market, by end user
6.3.2.7. Italy dialyzer market, by type
6.3.2.8. Italy dialyzer market, by end user
6.3.2.9. Spain dialyzer market, by type
6.3.2.10. Spain dialyzer market, by end user
6.3.2.11. Russia dialyzer market, by type
6.3.2.12. Russia dialyzer market, by end user
6.3.2.13. Austria dialyzer market, by type
6.3.2.14. Austria dialyzer market, by end user
6.3.2.15. Rest of Europe dialyzer market, by type
6.3.2.16. Rest of Europe dialyzer market, by end user
6.3.3. Europe dialyzer market, by type
6.3.4. Europe dialyzer market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan dialyzer market, by type
6.4.2.2. Japan dialyzer market, by end user
6.4.2.3. China dialyzer market, by type
6.4.2.4. China dialyzer market, by end user
6.4.2.5. India dialyzer market, by type
6.4.2.6. India dialyzer market, by end user
6.4.2.7. Australia dialyzer market, by type
6.4.2.8. Australia dialyzer market, by end user
6.4.2.9. South Korea dialyzer market, by type
6.4.2.10. South Korea dialyzer market, by end user
6.4.2.11. Taiwan dialyzer market, by type
6.4.2.12. Taiwan dialyzer market, by end user
6.4.2.13. Thailand dialyzer market, by type
6.4.2.14. Thailand dialyzer market, by end user
6.4.2.15. Malaysia dialyzer market, by type
6.4.2.16. Malaysia dialyzer market, by end user
6.4.2.17. Indonesia dialyzer market, by type
6.4.2.18. Indonesia dialyzer market, by end user
6.4.2.19. Rest of Asia-Pacific dialyzer market, by type
6.4.2.20. Rest of Asia-Pacific dialyzer market, by end user
6.4.3. Asia-Pacific dialyzer market, by type
6.4.4. Asia-Pacific dialyzer market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil dialyzer market, by type
6.5.2.2. Brazil dialyzer market, by end user
6.5.2.3. Saudi Arabia dialyzer market, by type
6.5.2.4. Saudi Arabia dialyzer market, by end user
6.5.2.5. South Africa dialyzer market, by type
6.5.2.6. South Africa dialyzer market, by end user
6.5.2.7. Turkey dialyzer market, by type
6.5.2.8. Turkey dialyzer market, by end user
6.5.2.9. Rest of LAMEA dialyzer market, by type
6.5.2.10. Rest of LAMEA dialyzer market, by end user
6.5.3. LAMEA dialyzer market, by type
6.5.4. LAMEA dialyzer market, by end user
Chapter: 7: COMPANY PROFILES
7.1. ASAHI KASEI CORPORATION
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. BAXTER INTERNATIONAL INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. BROWNDOVE HEALTHCARE (P) LTD.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. BAIN MEDICAL EQUIPMENT
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product Portfolio
7.6. FRESENIUS MEDICAL CARE AG & CO. KGAA
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product Portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. KAWASUMI LABORATORIES INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segment
7.7.4. Product Portfolio
7.7.5. Business performance
7.8. MEDTRONIC PLC. (BELCO)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. NIKKISO CO., LTD.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. JIHUA MEDICAL APPARATUS & INSTRUMENTS CO., LTD
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.11. ALLMED MEDICAL CARE HOLDINGS LIMITED
7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Product Portfolio
7.12. WEIGAO GROUP
7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Product Portfolio
7.12.5. Business performance
7.13. FARMASOL
7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Operating business segments
7.13.4. Product Portfolio
7.14. CHINA CHENGDU WESLEY BIOTECH CO., LTD
7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Operating business segments
7.14.4. Product Portfolio
7.15. TORAY INDUSTRIES, INC.
7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Operating business segments
7.15.4. Product Portfolio
7.15.5. Business performance
7.16. MEDICA GROUP
7.16.1. Company overview
7.16.2. Company snapshot
7.16.3. Operating business segments
7.16.4. Product Portfolio
7.17. JMS CO. LTD.
7.17.1. Company overview
7.17.2. Company snapshot
7.17.3. Operating business segments
7.17.4. Product Portfolio
7.17.5. Business performance
7.18. JIANGSU LENGTHEN LIFE SCIENCE AND TECHNOLOGY CO., LTD
7.18.1. Company overview
7.18.2. Company snapshot
7.18.3. Operating business segments
7.18.4. Product Portfolio
7.19. MEDIVATORS, INC.
7.19.1. Company overview
7.19.2. Company snapshot
7.19.3. Operating business segments
7.19.4. Product Portfolio
7.20. DIALIFEGROUP.COM
7.20.1. Company overview
7.20.2. Company snapshot
7.20.3. Operating business segments
7.20.4. Product Portfolio
